These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32056140)

  • 1. Scleral Fixation of the Fluocinolone Acetonide Implant in Eyes with Severe Iris-Lens Diaphragm Disruption and Recalcitrant CME: The Fluocinolone-Loop-Anchoring Technique (FLAT).
    Herold TR; Liegl R; Koenig S; Almarzooqi A; Priglinger SG; Wolf A
    Ophthalmol Ther; 2020 Mar; 9(1):175-179. PubMed ID: 32056140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleral fixation of fluocinolone acetonide implant.
    Tabandeh H; Rezaei K
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100775. PubMed ID: 32577584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LONG-TERM EFFICACY OF FLUOCINOLONE IN EYES WITH IRIS-LENS DIAPHRAGM DISRUPTION AND PCME WITH MEDICATION FIXED IN THE SCLERA (MEFISTO).
    Herold TR; Vounotrypidis E; Liegl R; Koenig SF; Priglinger SG; Wolf A
    Retina; 2022 Jul; 42(7):1392-1398. PubMed ID: 35321998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine-Gass Syndrome.
    Marques JH; Abreu AC; Silva N; Meireles A; Pessoa B; Melo Beirão J
    Int Med Case Rep J; 2021; 14():127-132. PubMed ID: 33664598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BILATERAL INTRAVITREAL 0.19-MG FLUOCINOLONE ACETONIDE IMPLANT FOR PERSISTENT NONDIABETIC CYSTOID MACULAR EDEMA AFTER VITRECTOMY.
    Ong SS; Walter SD; Chen X; Thomas AS; Finn AP; Fekrat S
    Retin Cases Brief Rep; 2021 May; 15(3):261-265. PubMed ID: 30015770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INJECTABLE FLUOCINOLONE IMPLANT FOR THE MANAGEMENT OF CHRONIC POSTSURGICAL CYSTOID MACULAR EDEMA IN VITRECTOMIZED EYES.
    Patel KG; Flores J; Abbey AM
    Retina; 2023 Oct; 43(10):1732-1737. PubMed ID: 37267632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on clinical pathophysiology of pseudophakic/aphakic eyes--a journey of 4 decades].
    Miyake K
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):214-45; discussion 246. PubMed ID: 18411712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior migration of intravitreal fluocinolone acetonide (Iluvien®) implant in a pseudophakic eye with intact posterior capsule.
    Alzaabi M; Taguri AH; Elbarky A
    Am J Ophthalmol Case Rep; 2020 Dec; 20():100922. PubMed ID: 32995665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluocinolone acetonide for the treatment of diabetic macular edema.
    Veritti D; Sarao V; Diplotti L; Samassa F; Lanzetta P
    Expert Opin Pharmacother; 2017 Oct; 18(14):1507-1516. PubMed ID: 28764565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystoid macular oedema and iris-fixated intraocular lens treated with intraocular lens exchange: A case series and review.
    Massa HF; Gobej I; Jacquier P; Jonescu-Cuypers C; Le Quoy O
    J Int Med Res; 2019 Jan; 47(1):188-195. PubMed ID: 30270801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Technique for Repositioning of a Migrated ILUVIEN(®) (Fluocinolone Acetonide) Implant into the Anterior Chamber.
    El-Ghrably IA; Saad A; Dinah C
    Ophthalmol Ther; 2015 Dec; 4(2):129-33. PubMed ID: 26199036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study.
    Singer MA; Sheth V; Mansour SE; Coughlin B; Gonzalez VH
    Ophthalmology; 2022 Jun; 129(6):605-613. PubMed ID: 35063472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients.
    Studsgaard A; Clemmensen KØ; Nielsen MS
    Graefes Arch Clin Exp Ophthalmol; 2022 May; 260(5):1633-1639. PubMed ID: 34851465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluocinolone intravitreal implant (Iluvien) for macular edema secondary to immune recovery uveitis in patient with acute myeloid leukemia.
    Cachero Rodríguez JM; Artaraz J; Imaz N; Fonollosa A
    J Ophthalmic Inflamm Infect; 2024 May; 14(1):19. PubMed ID: 38700565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching to intravitreal fluocinolone acetonide implant for refractory diabetic macular edema: 12- and 24-month results.
    Chronopoulos A; Chronopoulos P; Ashurov A; Korb C; Pfeiffer N; Hattenbach LO
    Eur J Ophthalmol; 2022 Jan; 32(1):443-449. PubMed ID: 33601897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema.
    Weber LF; Marx S; Auffarth GU; Scheuerle AF; Tandogan T; Mayer C; Khoramnia R
    J Ophthalmic Inflamm Infect; 2019 Jan; 9(1):3. PubMed ID: 30694420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert).
    Patel CC; Mandava N; Oliver SC; Braverman R; Quiroz-Mercado H; Olson JL
    Retina; 2012 Mar; 32(3):537-42. PubMed ID: 21963487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic macular edema outcomes in eyes treated with fluocinolone acetonide 0.2 µg/d intravitreal implant: real-world UK experience.
    El-Ghrably I; Steel DHW; Habib M; Vaideanu-Collins D; Manvikar S; Hillier RJ
    Eur J Ophthalmol; 2017 May; 27(3):357-362. PubMed ID: 28165610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal Sustained-Release Steroid Implants for the Treatment of Macular Edema following Surgical Removal of Epiretinal Membranes.
    Hattenbach LO; Springer-Wanner C; Hoerauf H; Callizo J; Jungmann S; Brauns T; Fulle G; Eichel S; Koss MJ; Kuhli-Hattenbach C
    Ophthalmologica; 2017; 237(4):232-237. PubMed ID: 28463851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuous to continuous therapy for persistent diabetic macular edema leads to reduction in treatment frequency.
    Adams OE; Schechet SA; Hariprasad SM
    Eur J Ophthalmol; 2021 Mar; 31(2):612-619. PubMed ID: 31964171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.